Rhoifolin potentiates the anti-cancer activity of doxorubicin in MDA-MB-231 triple-negative breast cancer cells


	Photomicrographs showing the effect of Dox, rhoifolin, and their combination on MDA-MB-231 migration after 72 h.

Part of: Al-Radaideh AS, Abbas MA, Al-Kabariti AY, Alqaraleh M, Madi R, Obeidat R (2025) Rhoifolin potentiates the anti-cancer activity of doxorubicin in MDA-MB-231 triple-negative breast cancer cells. Pharmacia 72: 1-9. https://doi.org/10.3897/pharmacia.72.e148600